Diversigen

Houston, United States Founded: 2013 • Age: 13 yrs Acquired By OraSure
Metagenomic services for the health, agriculture, and oil and gas industries.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors 11 Brand Intelligence

About Diversigen

Diversigen is a company based in Houston (United States) founded in 2013 was acquired by OraSure in November 2019. Diversigen operates in a competitive market with competitors including Trace Genomics, Kallyope, AnimalBiome, BGI and Genewiz, among others.

  • Headquarter Houston, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    OraSure

    (Nov 06, 2019)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

People of Diversigen

Headcount 10-50
Employee Profiles 5
Board Members and Advisors 4
Employee Profiles
People
Kathleen Weber
President, Diversigen & President, Molecular Solutions
People
Brittany Guerrero
Inside Business Development Specialist
People
Michael V.
Sr. Lab Operations Manager

Unlock access to complete

Board Members and Advisors
people
Dan Knights
Advisor
people
Daryl Gohl
Advisor
people
Kenny Beckman
Advisor
people
Eric Pamer
Advisor

Unlock access to complete

Funding Insights of Diversigen

Investors in Diversigen

Diversigen has secured backing from 1 investor. Prominent investors backing the company include OraSure Technologies.

All
Investor Description Founded Year Domain Location
Point-of-care diagnostic devices for oral fluid specimens are provided.
Founded Year Domain Location

Investments & Acquisitions by Diversigen

Investments

Financial Statements - Diversigen

Diversigen Comparisons

+
Add Comparison
Available on Premium

Competitors of Diversigen

Diversigen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Trace Genomics, Kallyope, AnimalBiome, BGI and Genewiz, among others.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Developer of technologies to diagnose soil health and soil-borne disease prediction
domain founded_year HQ Location
The gut-brain axis is explored for therapeutic and nutritional innovations.
domain founded_year HQ Location
Animal microbiome diagnostics services for pet care are offered.
domain founded_year HQ Location
BGI is engaged in genomics and precision medicine solutions.
domain founded_year HQ Location
Genomic services are provided for the life sciences industry.
domain founded_year HQ Location
Delivers comprehensive genome sequencing solutions for microbial analysis.

Latest news on Diversigen

Frequently Asked Questions about Diversigen

Diversigen was founded in 2013.

Diversigen is headquartered in Houston, United States. It is registered at Houston, Texas, United States.

Diversigen was founded in 2013 in Houston, United States, where metagenomic services are delivered to health, agriculture, and oil and gas industries. Offerings include 16S rRNA gene sequencing, 18S rRNA gene sequencing, whole genome shotgun sequencing, single organism genome sequencing, transcriptome sequencing, and viral metagenomic sequencing. These support applications in drug discovery, clinical research, diagnostics, crop protection, plant performance regulation, and oil and gas productivity enhancements.

Diversigen's top competitors include Trace Genomics, BGI and Kallyope.

Diversigen has 1 investor. Key investors include OraSure Technologies.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available